-
Categories
-
Tags
21 CFR 820.30 21 CFR Part 820 510(k) 510(k) Contents and Format 510(k) format and content 510(k) Requirements 510(k)s 510k 510k In Person Seminar 510k LIVE seminar 510k LIVE Webinar 510K Seminar 510k submission Adverse Event Reporting Adverse Event Reporting Systems Advertising and Promotion AERS AIMDD ANDA Animal Drugs Asian Country Big Data Biocompatibility Biologics Biosimilars BLA CAPA CDRH CE Mark China Complaint Complaint Handling David Lim Design Control Dr. David Lim Drugs EMA EN ISO 13485:2012 EN ISO 14971:2012 EU EU Marketing Authorization Application (MAA) FDA FDA 510(k) FDA 510(k) Seminar: Best Practices for 510(k) Preparation FDA Guidance FDA Inspection FDA-Regulated Industry FMEA Fundamentals of Regulatory Affairs Generics Global Compliance Seminar Hatch-Waxman Act Healthcare Industry Hong Kong Human Drug IDE IND ISO 13485 ISO 14155 IVDD IVDs Japan Korea Laws and Regulations LIVE 510(k) Webinar LIVE Online Seminar LIVE Webinar MAA to EMA in EU Mandatory Adverse Event Reporting Marketing Approvals for Generic Medicines MDD MDR Medical Device Medical Device Reporting Medical Devices Medicine NDA Opioid Abuse Opioid Addiction Opioids Pain Management Paragraph IV Certification Patent Patent Exclusivity PMA PMA Drafting Seminar PMA Seminar PMAs Postmarket Surveillance Postmarket Vigilance Pre-submission Premarket Approval Premarket Notification Q-Submission QSR Quality Risk Management Quality System Regulation Recorded Recorded 510k Seminar Recorded PMA Seminar reference listed drug Regulatory Affairs Regulatory Doctor Regulatory Plan Regulatory Plan/Strategy Regulatory Requirements Regulatory Strategy Risk Analysis Risk Management RLD Safety Signals Social Media Marketing Social Media Practice Social Media Practices SOPs Submission and Clearance | Global Compliance Seminar substantial equivalence UDI Unique Device Identification Unique Device Identifier US FDA US FDA 510(k) US RAC Exam Writing an Effective SOP
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
LIVE Online Seminar Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs in Medical Devices (“Device Program”)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees or $1,999 for up to five (5) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim serves as a Member of the Advisory Board for “Inspection Insider” published by the FDA News as well as for “International Journal of Vaccines and Immunizations.”
Four (4) Online Classes for Drugs
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Four (4) Online Classes for Medical Devices
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
LIVE Online Seminar Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs in Medical Devices (“Device Program”)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees or $1,999 for up to five (5) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim serves as a Member of the Advisory Board for “Inspection Insider” published by the FDA News as well as for “International Journal of Vaccines and Immunizations.”
Four (4) Online Classes for Drugs
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Four (4) Online Classes for Medical Devices
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
LIVE Online Seminar Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs in Medical Devices (“Device Program”)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees or $1,999 for up to five (5) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim serves as a Member of the Advisory Board for “Inspection Insider” published by the FDA News as well as for “International Journal of Vaccines and Immunizations.”
Four (4) Online Classes for Drugs
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Four (4) Online Classes for Medical Devices
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999
Two LIVE Online Programs in Regulatory Affairs
The Fundamentals of Regulatory Affairs for Drugs (“Drug Program“) and Medical Devices (“Device Program“)
Course Description
- Each class consists of 60-minutes of online seminar (LIVE or recorded)
- There are four classes for each program.
- The Drug Program begins on the First Mondays of January, March, May, July, September, November.
- LIVE | 10:00 AM PST | 01:00 PM | Flexible Scheduling | 60 Minutes
- The Device Program begins on the First Mondays of February, April, June, August, October, December.
- LIVE | 10:00 AM PST | 01:00 PM EST | | Flexible Scheduling | 60 Minutes
- Price for each program.
- $799 for one attendee
- $1,599 for up to three (3) attendees
- $1,999 for more than four (4) attendees
- $999 for recorded seminars (access to one attendee for 6 months) for either devices or drugs.
- Instructor: Dr. David Lim, President and Principal of REGULATORY DOCTOR
About the Instructor

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor. Dr. Lim frequently presents global laws, regulations, rules and guidance applicable to medical products. In particular, Dr. Lim provides seminars on various areas and focused-topics in regulatory affairs, clinical affairs, quality and regulatory compliance.
Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed the industry’s first PMA seminar series delivered online, helping global regulatory affairs professionals become a PMA pro. Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.
Drug Program: Four (4) Online Classes
- US Laws and Regulations Governing Drugs
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Drug Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational New Drug Application (IND): Content and Format
- New Drug Application (NDA): Content and Format
Device Program: Four (4) Online Classes
- US Laws and Regulations Governing Medical Devices including In Vitro Diagnostic (Medical) Devices (IVDs)
- FDA Guidance Documents and FDA-(Non)-Recognized Standards
- Medical Device Development, Good Laboratory Practice (GLP) and Good Clinical Practice (GCP)
- Investigational Device Exemption (IDE): Content and Format
- Premarket Notification (510(k)) and Premarket Approval (PMA) Application
Registration Options
NOTE: upon registration, you will receive an email to schedule your online classes based on your availability and convenience.
- Option 1: you may send your “request to purchase” by email to Global Compliance Seminar
- Option 2: you may request an invoice by email to Global Compliance Seminar
- Option 3: you may purchase online below using a credit card or PayPal.
LIVE (one attendee for drugs): $799
LIVE (up to 3 attendees for drugs): $1599
LIVE (more than 4 attendees for drugs): $1999
LIVE (one attendee for devices): $799
LIVE (up to 3 attendees for devices): $1599
LIVE (more than 4 attendees for devices): $1999
RECORDED for drugs: $999
RECORDED for devices: $999